0.10
Summit Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.66
FY23:
0.19
FY24:
0.42
FY25:
0.72
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.01
FY23:
0.01
FY24:
0.01
FY25:
0.03
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.66
FY23:
0.20
FY24:
0.44
FY25:
0.75
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.04
FY23:
0.02
FY24:
0.04
FY25:
0.07
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.50
FY23:
0.10
FY24:
0.01
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.13
FY23:
0.08
FY24:
0.39
FY25:
0.66
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.11
FY22:
0.66
FY23:
0.20
FY24:
0.44
FY25:
0.75
All amounts in billions USD